| Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy W Li, Y Jiang, J Lu International journal of pharmaceutics 634, 122655, 2023 | 11 | 2023 |
| Lipid-based nanotechnology: Liposome Y Jiang, W Li, Z Wang, J Lu Pharmaceutics 16 (1), 34, 2023 | 9 | 2023 |
| Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy Z Wang, W Li, Y Jiang, TB Tran, LE Cordova, J Chung, M Kim, G Wondrak, ... Nature Communications 14 (1), 7235, 2023 | 3 | 2023 |
| Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery Z Wang, W Li, Y Jiang, J Park, KM Gonzalez, X Wu, QY Zhang, J Lu Nature Communications 15 (1), 2073, 2024 | 2 | 2024 |
| Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapy Z Wang, W Li, Y Jiang, TB Tran, J Chung, M Kim, AJ Scott, J Lu Biomaterials 306, 122477, 2024 | 1 | 2024 |
| Evaluating Uptake of EGFR Targeted Phage-Like Particles in Bladder Cancer Cells Y Jiang University of Colorado Denver, Anschutz Medical Campus, 2022 | | 2022 |
